NMS Pharmaceuticals Inc. Monday said it will...
NMS Pharmaceuticals Inc. Monday said it will extend by one year the expiration of 600,000 warrants that had been scheduled to expire on July 21, 1986. First sold in 1983 for 25 cents apiece, each warrant can be traded for a share of NMS common stock at a conversion price of $7.75 a share. Traded over-the-counter, NMS stock closed Monday at $5.25 a share. A company spokesman said the low price prompted the decision to extend the warrants. Based in Newport Beach, NMS develops drug delivery systems and diagnostic test kits.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
